|
Eliot M. Lurier has been our Vice President, Finance and Administration, Chief Financial Officer since April 2005. From 2004 to 2005, he served as Consulting Chief Financial Officer to Bridge Pharmaceuticals, Inc., a spin off of SRI International focusing on drug development services in Asia. From 2002 to 2004, Mr. Lurier served as Consulting Chief Financial Officer to Linden Bioscience Inc., a venture backed integrator of functional genomics technology. From 2000 to 2002, he served as Chief Financial Officer and Treasurer of Admetric Biochem, Inc., a venture backed company. From 1998 to 2000, Mr. Lurier was Chief Financial Officer and Vice President Finance of Ascent Pediatrics, Inc., a publicly traded pediatric pharmaceutical company. He holds a B.S. in Accounting from Syracuse University and is a certified public accountant in Massachusetts. Mr. Lurier resides in Natick, Massachusetts. | 